Editions:  Austria · Denmark · France · Germany · Italy · Norway · Spain · Sweden · Switzerland

AstraZeneca settles Crestor lawsuit

Share this article

AstraZeneca settles Crestor lawsuit
14:58 CET+01:00
Anglo-Swedish pharmaceutical company AstraZeneca on Monday said it had settled a long-running patent lawsuit over its top-selling drug Crestor.

AstraZeneca said in a statement that the deal would protect its sales of the anti-cholesterol drug until 2016.

"AstraZeneca today announced that it has entered into a settlement agreement in its US patent infringement litigation against Watson Laboratories, Inc., Actavis, Inc. (formerly known as Watson Pharmaceuticals, Inc.), and EGIS Pharmaceuticals," the company said.

Crestor generated $6.25 billion of sales in 2012, down from $6.6 billion in 2011 after losing patent protection in certain regions.

AstraZeneca's announcement comes after it last week said it was cutting 3,900 jobs - in a major restructuring of the group over the next three years.

The group currently employs about 57,000 staff worldwide.

AFP/The Local/og

Follow The Local on Twitter

Get notified about breaking news on The Local

Share this article

The Local is not responsible for content posted by users.
Become a Member or sign-in to leave a comment.
Advertisement

From our sponsors

Change the world with a master's degree from Sweden's Linköping University

Master's students at world-leading Linköping University (LiU) aren't there simply to study. They solve real-world problems alongside experts in fields that can create a better tomorrow. Do you have what it takes to join them?

Advertisement